Chemoinformaics analysis of Androsta-1,4-diene-3,17-dione
| Molecular Weight | 284.399 | nRot | 0 |
| Heavy Atom Molecular Weight | 260.207 | nRig | 22 |
| Exact Molecular Weight | 284.178 | nRing | 4 |
| Solubility: LogS | -3.868 | nHRing | 0 |
| Solubility: LogP | 3.088 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 45 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 3 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 19 | No. of Saturated Rings | 3 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 49.337 |
| nHD | 0 | BPOL | 25.813 |
| QED | 0.677 |
| Synth | 3.951 |
| Natural Product Likeliness | 2.568 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.976 |
| Pgp-sub | 0.015 |
| HIA | 0.005 |
| CACO-2 | -4.693 |
| MDCK | 0.0000297 |
| BBB | 0.159 |
| PPB | 0.920994 |
| VDSS | 1.302 |
| FU | 0.0507443 |
| CYP1A2-inh | 0.27 |
| CYP1A2-sub | 0.561 |
| CYP2c19-inh | 0.254 |
| CYP2c19-sub | 0.776 |
| CYP2c9-inh | 0.183 |
| CYP2c9-sub | 0.081 |
| CYP2d6-inh | 0.614 |
| CYP2d6-sub | 0.028 |
| CYP3a4-inh | 0.889 |
| CYP3a4-sub | 0.902 |
| CL | 18.356 |
| T12 | 0.848 |
| hERG | 0.046 |
| Ames | 0.02 |
| ROA | 0.785 |
| SkinSen | 0.937 |
| Carcinogencity | 0.887 |
| EI | 0.239 |
| Respiratory | 0.984 |
| NR-Aromatase | 0.633 |
| Antiviral | No |
| Prediction | 0.71637 |